• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe.

作者信息

Coleman Rosalind, Prins Maria

机构信息

PrEP consultant, The Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.

Public Health Service of Amsterdam and Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Euro Surveill. 2017 Oct;22(42). doi: 10.2807/1560-7917.ES.2017.22.42.17-00698.

DOI:10.2807/1560-7917.ES.2017.22.42.17-00698
PMID:29067904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5710114/
Abstract
摘要

相似文献

1
Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe.欧洲国家艾滋病毒预防计划中经济适用的暴露前预防（PrEP）选项。
Euro Surveill. 2017 Oct;22(42). doi: 10.2807/1560-7917.ES.2017.22.42.17-00698.
2
Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058.2018 年至 2058 年德国预防 HIV-1 感染的暴露前预防的成本效益和预算影响。
Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1800398.
3
Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy.人类免疫缺陷病毒感染暴露前预防的实施：研究与政策的进展及新出现的问题
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21108. doi: 10.7448/IAS.19.7.21108. eCollection 2016.
4
Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.模拟口服暴露前预防在 13 个资源匮乏国家的影响和成本效益。
J Int AIDS Soc. 2020 Feb;23(2):e25451. doi: 10.1002/jia2.25451.
5
[The role of biomedical interventions in HIV prevention: Pre-exposure Prophylaxis (PrEP)].生物医学干预措施在HIV预防中的作用：暴露前预防（PrEP）
Semergen. 2020 Apr;46(3):202-207. doi: 10.1016/j.semerg.2019.06.006. Epub 2019 Aug 5.
6
Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.中泰两国两所医院男男性行为者中开展暴露前预防的成本及成本效益分析。
J Int AIDS Soc. 2018 Jul;21 Suppl 5(Suppl Suppl 5):e25129. doi: 10.1002/jia2.25129.
7
Cost of implementing HIV pre-exposure prophylaxis at community-based clinics in Indonesia.在印度尼西亚的社区诊所实施艾滋病毒暴露前预防的成本。
Trop Med Int Health. 2024 Jan;29(1):13-22. doi: 10.1111/tmi.13946. Epub 2023 Nov 5.
8
Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.将暴露前预防（PrEP）的有效性转化为公共卫生影响：决策者在成本效益、价格、监管问题、分配正义及获取途径倡导方面的关键考量因素
J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):19973. doi: 10.7448/IAS.18.4.19973. eCollection 2015.
9
Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America.在拉丁美洲将暴露前预防作为艾滋病毒联合预防的一部分进行公平考量。
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21113. doi: 10.7448/IAS.19.7.21113. eCollection 2016.
10
Can we afford to offer pre-exposure prophylaxis to MSM in Catalonia? Cost-effectiveness analysis and budget impact assessment.我们是否有能力为加泰罗尼亚的男男性行为者提供暴露前预防？成本效益分析和预算影响评估。
AIDS Care. 2018 Jun;30(6):784-792. doi: 10.1080/09540121.2017.1417528. Epub 2017 Dec 20.

引用本文的文献

1
Oral PrEP use and intention to use long-acting PrEP regimens among MSM accessing PrEP via governmental and non-governmental provision pathways, 20 European countries, October 2023 to April 2024.2023年10月至2024年4月期间，20个欧洲国家通过政府和非政府提供途径获取暴露前预防（PrEP）的男男性行为者（MSM）中口服PrEP的使用情况及使用长效PrEP方案的意向。
Euro Surveill. 2025 Aug;30(34). doi: 10.2807/1560-7917.ES.2025.30.34.2500122.
2
Piloting the Impact of an e-Learning on Knowledge About HIV Prevention and Prophylaxis Among General Practitioners in Belgium.试行电子学习对比利时全科医生预防和治疗艾滋病毒知识的影响
J Med Educ Curric Dev. 2024 Oct 8;11:23821205241286293. doi: 10.1177/23821205241286293. eCollection 2024 Jan-Dec.
3
A psychosocial network approach studying biomedical HIV prevention uptake between 2017 and 2019.一项社会心理网络方法研究 2017 年至 2019 年期间生物医学 HIV 预防措施的采用情况。
Sci Rep. 2023 Sep 27;13(1):16168. doi: 10.1038/s41598-023-42762-2.
4
Knowledge domain and emerging trends in HIV pre-exposure prophylaxis: A visualization analysis CiteSpace.HIV暴露前预防的知识领域与新兴趋势：一种基于CiteSpace的可视化分析
Front Microbiol. 2023 Mar 16;14:1099132. doi: 10.3389/fmicb.2023.1099132. eCollection 2023.
5
Factors Predicting Uptake of Sexually Transmitted Infections Testing among Men Who Have Sex with Men Who Are "Pre-Exposure Prophylaxis Tourists"-An Observational Prospective Cohort Study.预测男男性行为者中“暴露前预防旅游”人群接受性传播感染检测的因素——一项观察性前瞻性队列研究。
Int J Environ Res Public Health. 2021 Mar 30;18(7):3582. doi: 10.3390/ijerph18073582.
6
Trends in Human Immunodeficiency Virus and Sexually Transmitted Infection Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men After Rapid Scale-up of Preexposure Prophylaxis in Victoria, Australia.澳大利亚维多利亚州暴露前预防快速推广后男男性行为者人类免疫缺陷病毒和性传播感染检测趋势。
Sex Transm Dis. 2020 Aug;47(8):516-524. doi: 10.1097/OLQ.0000000000001187.
7
Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.暴露前预防以预防 HIV 感染：2015-2016 年美国患者、处方者、接受情况和支出的横断面研究。
PLoS Med. 2020 Apr 10;17(4):e1003072. doi: 10.1371/journal.pmed.1003072. eCollection 2020 Apr.
8
Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib.补充保护证书及其对欧洲药品可及性的影响：索非布韦、曲妥珠单抗和伊马替尼的案例研究
J Pharm Policy Pract. 2020 Jan 14;13:1. doi: 10.1186/s40545-019-0198-6. eCollection 2020.
9
Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and emerging models of PrEP implementation.向人群提供暴露前预防（PrEP）：机会、挑战及PrEP实施的新兴模式
Sex Health. 2018 Nov;15(6):522-527. doi: 10.1071/SH18103.
10
Pre-exposure prophylaxis among men who have sex with men in the Amsterdam Cohort Studies: Use, eligibility, and intention to use.男男性行为者的暴露前预防：使用、资格和使用意向。
PLoS One. 2018 Oct 12;13(10):e0205663. doi: 10.1371/journal.pone.0205663. eCollection 2018.

本文引用的文献

1
Economic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016.2016年英国男男性行为者中HIV暴露前预防的经济学评估
Euro Surveill. 2017 Oct;22(42). doi: 10.2807/1560-7917.ES.2017.22.42.17-00192.
2
Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.男男性行为者和跨性别者在早期采用国家的暴露前预防。
AIDS. 2017 Oct 23;31(16):2179-2191. doi: 10.1097/QAD.0000000000001627.
3
Preexposure Prophylaxis: Adapting HIV Prevention Models to Achieve Worldwide Access.暴露前预防：调整艾滋病病毒预防模式以实现全球普及。
Am J Public Health. 2017 Oct;107(10):1534-1535. doi: 10.2105/AJPH.2017.304035.
4
PrEP in Europe - expectations, opportunities and barriers.欧洲的暴露前预防——期望、机遇与障碍
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21103. doi: 10.7448/IAS.19.7.21103. eCollection 2016.
5
Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study.荷兰预防 HIV-1 感染的暴露前预防的成本效益分析：一项数学建模研究。
Lancet Infect Dis. 2016 Dec;16(12):1423-1429. doi: 10.1016/S1473-3099(16)30311-5. Epub 2016 Sep 22.
6
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.暴露前预防以预防HIV-1感染（PROUD）：一项实用开放标签随机试验试点阶段的有效性结果
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.
7
A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia.澳大利亚男男性行为人群中 HIV 暴露前预防的成本效益分析。
Clin Infect Dis. 2014 Apr;58(7):1027-34. doi: 10.1093/cid/cit946. Epub 2014 Jan 2.
8
The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.美国男男性行为者中 HIV 预防的暴露前预防的成本效益。
Ann Intern Med. 2012 Apr 17;156(8):541-50. doi: 10.7326/0003-4819-156-8-201204170-00001.